[Hypoglycemia. 3].
D000818:Animals; D001120:Arginine / Q000009:adverse effects; D001645:Biguanides / Q000009:adverse effects; D003981:Diazoxide / Q000627:therapeutic use; D001728:Dicumarol / Q000494:pharmacology; D004357:Drug Synergism; D000431:Ethanol / Q000009:adverse effects; D005934:Glucagon / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007930:Leucine / Q000009:adverse effects; D051379:Mice; D011817:Rabbits; D051381:Rats; D013565:Sympatholytics / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects; D014993:Xylitol / Q000627:therapeutic use
D001645:Biguanides; D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D013565:Sympatholytics; D000431:Ethanol; D001728:Dicumarol; D005934:Glucagon; D001120:Arginine; D014044:Tolbutamide; D007930:Leucine; D005947:Glucose; D003981:Diazoxide; D014993:Xylitol
Hypoglykämie. 3.